chemical

Rociletinib CO-1686

HY-15729

10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg

61; 50; 80; 150; 250 USD

Rociletinib CO-1686

Chemical

10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg

61; 50; 80; 150; 250 USD

Rociletinib (CO-1686) is an orally delivered kinase inhibitor that specifically targets the mutant forms of EGFR including T790M, and the K i values for EGFRL858R/T790M and EGFRWT are 21.5 nM and 303.3 nM, respectively.

99.45%

Powder: -20°C, 3 years; 4°C, 2 years. In solvent: -80°C, 6 months; -20°C, 1 month.